FDA Clearance Tracker · P170029-S003
CALCIVIS Imaging System
Last checked: Nov 20, 2026Latest source record: Oct 13, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Oct 13, 2023
Approved
Time to decision
31 days
Received Sep 12, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P170029-S003
- Device name
- CALCIVIS Imaging System
- Applicant
- Calcivis Limited
- Applicant location
- Edinburgh
- Received
- Sep 12, 2023
- Decided
- Oct 13, 2023
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P170029
Device type
- Device class
- Class III
- Specialty
- Dentistry & Oral Surgery
FDA's approval statement
As written in FDA's record.
Approval for the CALCIVIS Imaging System is intended to be used by dental healthcare professionals on patients (6 years and older) with, or at risk of developing, demineralization associated with caries lesions, on accessible coronal tooth surfaces. The CALCIVIS Imaging System is indicated for use to provide images of active demineralization on tooth surfaces, as an aid to the assessment, diagnosis, monitoring and treatment planning of demineralization associated with caries lesions.
Source documents
Other decisions for Calcivis Limited
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P170029 · Decided Mar 7, 2023 · 1,988 days after receipt
Device type: Caries detection product with drug or biologic (QJX) · Dentistry & Oral Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.